精彩内容米内网数据显示，2025年前三季度中国零售药店终端（城市实体药店+网上药店）中成药销售额超过1000亿元，同比下滑约2.5%。201个中成药销售过亿，其中有91个逆势增长（详细名单见本文末），最高涨幅约1260%，步长、达仁堂独家品种亮眼，华润三九、北京同仁堂霸屏。超230亿元！12个中成药大卖从销售情况看，91个中成药2025年前三季度在中国零售药店终端的销售额合计超过230亿元。其中，...
Source Link精彩内容米内网数据显示，2025年前三季度中国零售药店终端（城市实体药店+网上药店）中成药销售额超过1000亿元，同比下滑约2.5%。201个中成药销售过亿，其中有91个逆势增长（详细名单见本文末），最高涨幅约1260%，步长、达仁堂独家品种亮眼，华润三九、北京同仁堂霸屏。超230亿元！12个中成药大卖从销售情况看，91个中成药2025年前三季度在中国零售药店终端的销售额合计超过230亿元。其中，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.